journal article·2010-03

A hydrogel-based stem cell delivery system to treat retinal degenerative diseases

Brian G. Ballios, Michael J. Cooke, Derek van der Kooy, Molly S. Shoichet

Biomaterials· Volume 31· Issue 9
Publisher page

Abstract

Regenerative strategies for retinal degenerative diseases are limited by poor cellular survival, distribution and integration after transplantation to the sub-retinal space. To overcome this limitations a stem cell delivery system was developed, taking advantage of the minimally-invasive, injectable and biodegradable properties of a blend of hyaluronan and methylcellulose (HAMC). The physical and biological properties of this unique HAMC formulation were studied. HAMC supported retinal stem-progenitor cell (RSPC) survival and proliferation in vitro. The blend was a viscous solution, exhibiting properties ideal for delivery to the sub-retinal space. In vivo transplantation studies in mice were carried out to investigate both the biodegradability of HAMC in the sub-retinal space over 7 days and the potential of HAMC as a cell delivery vehicle. RSPCs delivered in HAMC were more evenly distributed in the sub-retinal space than those delivered in traditional saline solutions, suggesting that HAMC is a promising vehicle for cellular delivery to the degenerating retina overcoming previously reported barriers to tissue integration in the retina such as cellular aggregation and non-contiguous distribution.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Retinal Development and Disorders · Retinal and Macular Surgery · Corneal Surgery and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Review and update: current treatment trends for patients with retinitis pigmentosa10.1016/j.optm.2008.01.026 ↗
2. Overview of epidemiologic studies of diabetic retinopathy10.1080/09286580701396720 ↗
3. Developments in age-related macular degeneration: diagnosis and treatment
4. Important causes of visual impairment in the world today10.1001/jama.290.15.2057 ↗
5. Ocular neovascularization: an epidemiologic review10.1016/S0039-6257(98)00035-6 ↗
6. Ranibizumab for neovascular age-related macular degeneration10.1056/NEJMoa054481 ↗
7. New paradigms in the treatment of wet AMD: the impact of anti-VEGF therapy10.1038/eye.2009.13 ↗
8. Current and future pharmacological intervention for diabetic retinopathy10.1517/14728214.10.2.441 ↗
9. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD10.1177/112067219900900310 ↗
10. Human fetal RPE transplants in age related macular degeneration (ARMD)
11. Transplantation of neural retina in patients with retinitis pigmentosa
12. Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration10.1111/j.1442-9071.2009.01915.x ↗
13. RPE transplantation and its role in retinal disease10.1016/j.preteyeres.2007.07.001 ↗
14. Neural retinal cell transplantation: ideal versus reality10.1016/S0161-6420(99)90134-3 ↗
15. Stem cells and retinal repair10.1016/j.preteyeres.2004.01.002 ↗
16. Stem cells as tools in regenerative therapy for retinal degeneration10.1001/archophthalmol.2009.65 ↗
17. Stem cell therapy for retinal degeneration: retinal neurons from heterologous sources10.1080/08820530590921882 ↗
18. Retinal stem cells in the adult mammalian eye10.1126/science.287.5460.2032 ↗
19. Facile isolation and the characterization of human retinal stem cells10.1073/pnas.0401596101 ↗
20. Human stem cell ethics: beyond the embryo10.1016/j.stem.2008.05.005 ↗
21. Robust neural integration from retinal transplants in mice deficient in GFAP and vimentin10.1038/nn1088 ↗
22. Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior10.1167/iovs.04-0511 ↗
23. Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation10.1016/j.biomaterials.2009.02.046 ↗
24. Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thin-film poly(e-caprolactone) nanowire scaffold10.1007/s12177-008-9005-3 ↗
25. A microfabricated scaffold for retinal progenitor cell grafting10.1016/j.biomaterials.2007.10.007 ↗
26. Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space10.1039/b618583e ↗
27. Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells10.1634/stemcells.2005-0111 ↗
28. Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors10.1016/j.biomaterials.2004.08.022 ↗
29. Eye surgery in the elderly10.1016/S1521-6896(03)00006-5 ↗
30. In vitro and in vivo behaviour of biodegradable and injectable PLA/PGA copolymers related to different matrices10.1177/039139880703000412 ↗
31. Collagen gel systems for sustained delivery and tissue engineering10.1016/j.addr.2003.08.004 ↗
32. Novel injectable neutral solutions of chitosan form biodegradable gels in situ10.1016/S0142-9612(00)00116-2 ↗
33. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord10.1016/j.biomaterials.2005.11.015 ↗
34. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair10.1089/ten.tea.2007.0349 ↗
35. An injectable drug delivery platform for sustained combination therapy10.1016/j.jconrel.2009.05.009 ↗
36. Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord10.1016/S0079-6123(06)61027-3 ↗
37. Medical applications of hyaluronan and its derivatives
39. Hyaluronate derivatives in drug delivery10.1615/CritRevTherDrugCarrierSyst.v15.i5.30 ↗
40. Hyaluronan and the functional organization of the interphotoreceptor matrix
41. Hyaluronan in the interphotoreceptor matrix of the eye: species differences in content, distribution, ligand binding and degradation10.1006/exer.1997.0422 ↗
42. Loss of retinal progenitor cells leads to an increase in the retinal stem cell population in vivo10.1111/j.1460-9568.2005.04537.x ↗
43. Characteristics of progenitor cells derived from adult ciliary body in mouse, rat, and human eyes10.1167/iovs.06-1034 ↗
44. Observational examination of aggregation and migration during early phase of neurosphere culture of mouse neural stem cells10.1263/jbb.104.231 ↗
45. Visual function and dysfunction in early and late age-related maculopathy10.1016/j.preteyeres.2005.11.002 ↗
46. The use of progenitor cell/biodegradable MMP2-PLGA polymer constructs to enhance cellular integration and retinal repopulation10.1016/j.biomaterials.2009.09.015 ↗
47. Human vitreous hyaluronidase: isolation and characterization10.3109/02713689608995150 ↗
48. Lysosomal hyaluronidase in the subretinal fluid of patients with rhegmatogenous retinal detachments10.1016/0002-9394(82)90191-X ↗
49. Spare the rod and spoil the eye10.1136/bjo.2004.062547 ↗
50. Mouse models of age-related macular degeneration10.1016/j.exer.2005.10.012 ↗
51. Molecular pathology of age-related macular degeneration10.1016/j.preteyeres.2008.10.001 ↗